This fully integrated transnational pharmaceutical company focuses on developing high-quality formulations to address unmet medical needs. They boast a strong presence in the Indian market and expanding global reach, offering both branded and generic medications, as well as APIs. Their state-of-the-art WHO-GMP certified production facility in Mehsana is equipped to manufacture a wide range of dosage forms, including tablets, capsules, liquids, creams, ointments, and injectables. The company prioritizes innovation, with a pipeline of new products targeting areas like opioid addiction treatment. Key therapy areas include antibacterials, anti-infectives, anti-diarrheals, pain management, anemia management, and opioid de-addiction. They hold product patents and adhere to stringent regulatory guidelines from authorities like the USFDA, EDQM, MHRA, and MCA. Their products are distributed across various regions, including the EU and North America.